News & Media

BillionToOne Announces Medicare Coverage for Northstar Select®

BillionToOne’s Northstar Response® Validated in New Peer-Reviewed Study, Building on Previous Clinical Research

BillionToOne appoints Dr. Gary Palmer as Chief Medical Officer, Oncology; Launches Northstar Select™ and Northstar Response™ Liquid Biopsy Assays for Commercial Use

January 23, 2023

BillionToOne launches oncology liquid biopsy products for research use & announces clinical research collaboration with UCSD

BillionToOne Pushing Forward in Cancer Diagnostics With First Data on Response Monitoring Test

Medicare Covering BillionToOne Northstar Select Cancer Liquid Biopsy Test

Methylation Monitoring Predicts Pan-Cancer Outcomes

General Information

The Power of One: Using Single Molecule Sensitivity Diagnostics to Fight Cancer

February 4, 2025

ASCO24: BillionToOne unveils results from tumour profiling test comparison

With New Validation Data, BillionToOne Boosts Commercial Prospects of Therapy Selection Assay

Act with certainty. Adapt with precision.